Related Experiment Videos
[Thrombolytic therapy for acute myocardial infarction in the general internal medicine ward]
M Błasiak1, G Pacyk, B Zawadowicz
1Oddziału Chorób Wewnetrznych Wojewódzkiego Szpitala Zespolonego w Czestochowie.
Insights
Intravenous streptokinase effectively treats acute myocardial infarction, achieving artery recanalization in over 74% of patients. This thrombolytic therapy is safe and feasible even in district hospitals without advanced cardiac facilities.
Area of Science:
- Cardiology
- Emergency Medicine
Background:
- Acute myocardial infarction (AMI) is a leading cause of mortality.
- Timely reperfusion therapy is crucial for improving outcomes in AMI patients.
Purpose of the Study:
- To evaluate the safety and efficacy of intravenous streptokinase for AMI treatment.
- To assess the feasibility of thrombolytic therapy in a district hospital setting.
Main Methods:
- A 4-year study involving 59 AMI patients treated with intravenous streptokinase.
- Treatment administered within an average of 3 hours from symptom onset.
- Patient selection and treatment protocols were strictly followed.
- Reperfusion assessed using indirect criteria.
Main Results:
- Successful artery recanalization achieved in 74.6% of patients.
- Complications were infrequent and generally not severe.
- Most complications occurred within the first 24 hours of hospitalization.
- Fewer complications were observed after the initial 24-hour period.
Conclusions:
- Intravenous streptokinase is a safe and effective treatment for AMI.
- Thrombolytic therapy with streptokinase can be successfully implemented in district hospitals.
- This approach is valuable in settings lacking cardiac catheterization and cardiosurgery facilities.
Abstract:
During a 4-year period, 59 patients with the acute myocardial infarction were treated at the ICU of the district hospital. Streptokinase, used for the treatment, was given i.v. after and average period of 3 hours following the onset of stenocardia. Elaborated protocol was observed as to the selection of patients for thrombolytic therapy and its tactics. Basing on the indirect criteria of reperfusion, a recanalization of the occluded artery was noted in 74.6% of the treated patients. Complications occurred most frequently during the first 24 hours of the hospitalisation. None was serious enough to require special therapeutic measures. Complications of the thrombolytic treatment were less frequent after the first day of the hospitalisation. Thrombolytic treatment of the acute myocardial infarction with intravenous streptokinase is safe and effective, and may successfully be carried out also in district hospitals in which cardiac catheterization and cardiosurgery are inaccessible.